药物银行_药药网

DB10301||

名称

Human papillomavirus type 16 L1 capsid protein antigen

描述

Human papillomavirus type 16 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) types 6, 11, 16 and 18. The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, and 18, which are produced by separate fermentations in recombinant *Saccharomyces cerevisiae* and self-assembled into VLPs.

cas号

唯一标识码

6LTE2DNX63

状态

一般参考文献

组

approved,investigational,

指示

药效学

作用机制

毒性

代谢

吸收

半衰期

分类

消除途径

种类

Actively Acquired Immunity

Inactivated Human Papillomavirus Vaccine

盐类

蛋白质结合

清除

同义词

language:english; code:; name;L1 protein, Human papillomavirus type 16 Vaccine
language:english; code:; name;Recombinant human papillomavirus type 16 L1 protein

国际品牌

配送量

产品

name:Cervarix
labeller:Glaxosmithkline Inc
ndc-id:
ndc-product-code:
dpd-id:02342227
ema-product-code:
ema-ma-number:
started-marketing-on:2010-02-10
ended-marketing-on:
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Gardasil
labeller:Remedy Repack
ndc-id:
ndc-product-code:52125-833
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-02-13
ended-marketing-on:2015-02-11
dosage-form:Injection, suspension
strength:
route:Intramuscular
fda-application-number:BLA125126
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gardasil
labeller:Merck Sharp & Dohme Corp.
ndc-id:
ndc-product-code:0006-4045
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-06-08
ended-marketing-on:
dosage-form:Injection, suspension
strength:
route:Intramuscular
fda-application-number:BLA125126
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gardasil
labeller:Merck Sharp & Dohme Corp.
ndc-id:
ndc-product-code:0006-4109
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-06-08
ended-marketing-on:
dosage-form:Injection, suspension
strength:
route:Intramuscular
fda-application-number:BLA125126
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gardasil
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-1523
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-06-08
ended-marketing-on:
dosage-form:Injection, suspension
strength:
route:Intramuscular
fda-application-number:BLA125126
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gardasil
labeller:Merck Ltd.
ndc-id:
ndc-product-code:
dpd-id:02283190
ema-product-code:
ema-ma-number:
started-marketing-on:2006-08-16
ended-marketing-on:2019-08-22
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Gardasil 9
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-2443
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-12-10
ended-marketing-on:
dosage-form:Injection, suspension
strength:
route:Intramuscular
fda-application-number:BLA125508
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gardasil 9
labeller:Merck Sharp & Dohme Corp.
ndc-id:
ndc-product-code:0006-4119
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-12-10
ended-marketing-on:
dosage-form:Injection, suspension
strength:
route:Intramuscular
fda-application-number:BLA125508
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gardasil 9
labeller:Merck Sharp & Dohme Corp.
ndc-id:
ndc-product-code:0006-4121
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-12-10
ended-marketing-on:
dosage-form:Injection, suspension
strength:
route:Intramuscular
fda-application-number:BLA125508
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gardasil 9
labeller:Msd Vaccins
ndc-id:
ndc-product-code:
dpd-id:
ema-product-code:EMEA/H/C/003852
ema-ma-number:EU/1/15/1007/001
started-marketing-on:2015-06-09
ended-marketing-on:
dosage-form:Injection, suspension
strength:
route:Intramuscular
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:EU
source:EMA
name:Gardasil 9
labeller:Merck Ltd.
ndc-id:
ndc-product-code:
dpd-id:02437058
ema-product-code:
ema-ma-number:
started-marketing-on:2015-03-18
ended-marketing-on:
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD

混合物

name:Gardasil
ingredients:Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen
name:Gardasil 9
ingredients:Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 31 L1 capsid protein antigen + Human papillomavirus type 33 L1 capsid protein antigen + Human papillomavirus type 45 L1 capsid protein antigen + Human papillomavirus type 52 L1 capsid protein antigen + Human papillomavirus type 58 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen
name:Gardasil
ingredients:Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen
name:Gardasil
ingredients:Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen
name:Gardasil
ingredients:Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen
name:Gardasil 9
ingredients:Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 31 L1 capsid protein antigen + Human papillomavirus type 33 L1 capsid protein antigen + Human papillomavirus type 45 L1 capsid protein antigen + Human papillomavirus type 52 L1 capsid protein antigen + Human papillomavirus type 58 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen
name:Gardasil 9
ingredients:Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 31 L1 capsid protein antigen + Human papillomavirus type 33 L1 capsid protein antigen + Human papillomavirus type 45 L1 capsid protein antigen + Human papillomavirus type 52 L1 capsid protein antigen + Human papillomavirus type 58 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen
name:Gardasil 9
ingredients:Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 31 L1 capsid protein antigen + Human papillomavirus type 33 L1 capsid protein antigen + Human papillomavirus type 45 L1 capsid protein antigen + Human papillomavirus type 52 L1 capsid protein antigen + Human papillomavirus type 58 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen
name:Gardasil
ingredients:Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen
name:Cervarix
ingredients:Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen
name:Gardasil 9
ingredients:Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 31 L1 capsid protein antigen + Human papillomavirus type 33 L1 capsid protein antigen + Human papillomavirus type 45 L1 capsid protein antigen + Human papillomavirus type 52 L1 capsid protein antigen + Human papillomavirus type 58 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen

包装者

生产者

价格

受影响的生物体

剂量

form:Injection, solution
route:
strength:20 mcg/0.5mL
form:Suspension
route:Intramuscular
strength:20 mcg
form:Injection, suspension
route:Intramuscular
strength:
form:Injection, suspension
route:Intramuscular
strength:40 mcg/0.5mL
form:Injection, suspension
route:Intramuscular; Parenteral
strength:20 mcg
form:Suspension
route:Intramuscular
strength:
form:Suspension
route:Intramuscular
strength:20 µg
form:Injection, suspension
route:Intramuscular; Parenteral
strength:40 µg
form:Injection, suspension
route:Intramuscular
strength:40 ug/0.5mL
form:Injection, solution
route:Intramuscular
strength:40 mcg
form:Injection, suspension
route:Intramuscular
strength:40 mcg
form:Suspension
route:Intramuscular
strength:40 mcg

atc代码

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

序列

实验性质

外部标识符

resource：Drugs Product Database (DPD)
identifier：19709
resource：PubChem Substance
identifier：347910487
resource：RxCUI
identifier：798264

外部链接

路径

目标

酶

载体

运输工具

药物反应

效应

不良反应

目录